Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person renal cell carcinoma

Class:Id	Disease:9685402
_displayName	renal cell carcinoma
_timestamp	2020-04-23 13:12:10
created	[InstanceEdit:9685409] Jassal, Bijay, 2020-04-23
definition	A renal carcinoma that has_material_basis_in the lining of the proximal convoluted renal tubule of the kidney.
identifier	4450
name	renal cell carcinoma
referenceDatabase	[ReferenceDatabase:1247631] DOID
synonym	RCC adenocarcinoma of kidney hypernephroma
(disease)	[ProteinDrug:9679411] nivolumab [extracellular region] [EntityWithAccessionedSequence:9691055] p-6Y FLT3 V579I [plasma membrane] [Homo sapiens] [EntityWithAccessionedSequence:9691056] FLT3 V579I [plasma membrane] [Homo sapiens] [Complex:9691106] FLT3 V579I dimer [plasma membrane] [Homo sapiens] [Complex:9691114] p-6Y FLT3 V579I dimer [plasma membrane] [Homo sapiens] [EntityWithAccessionedSequence:9713472] VCL(1-811)-p-7Y-ALK(1058-1620) fusion [cytosol] [Homo sapiens] [EntityWithAccessionedSequence:9713480] VCL(1-811)-ALK(1058-1620) fusion [cytosol] [Homo sapiens] [Complex:9713498] VCL(1-811)-ALK(1058-1620) fusion dimer [cytosol] [Homo sapiens] [Complex:9713506] VCL(1-811)-p-7Y ALK(1058-1620) fusion dimer [cytosol] [Homo sapiens] [ProteinDrug:9726229] ipilimumab [extracellular region]
[Change default viewing format]

No pathways have been reviewed or authored by renal cell carcinoma (9685402)